TXG (10x Genomics) Construction In Progress: $2.5 Mil (As of Mar. 2026)


TXG 10x Genomics Inc TXG
62 GF Score
Price $36.75
GF Value $19.00
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is 10x Genomics Construction In Progress?

10x Genomics TXG +2.85% 62 Construction In Progress is $2.5 Mil as of Mar. 2026. GuruFocus rates TXG with a GF Score™ of 62/100 and a GF Value™ of $19.00 (Significantly Overvalued). The stock has 8 warning signs investors should review.

10x Genomics's quarterly construction in progress increased from Sep. 2025 ($2.5 Mil) to Dec. 2025 ($2.9 Mil) but then declined from Dec. 2025 ($2.9 Mil) to Mar. 2026 ($2.5 Mil).

10x Genomics's annual construction in progress declined from Dec. 2023 ($7.3 Mil) to Dec. 2024 ($5.2 Mil) and declined from Dec. 2024 ($5.2 Mil) to Dec. 2025 ($2.9 Mil).

10x Genomics Construction In Progress Historical Data

* Premium members only.

The historical data trend for 10x Genomics's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

10x Genomics Construction In Progress Chart

10x Genomics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only 52.19 153.00 7.25 5.15 2.93

10x Genomics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.48 2.74 2.53 2.93 2.53
TXG
62GF Score
10x Genomics Inc TXG
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

10x Genomics Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of $2.5 Mil mean?
10x Genomics (TXG) has a Construction In Progress of $2.5 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on 10x Genomics and its competitors.
Is 10x Genomics' Construction In Progress too high?
10x Genomics' current Construction In Progress is $2.5 Mil. Overall, 10x Genomics has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 10x Genomics' Construction In Progress compare to WAY and DOCS?
10x Genomics' Construction In Progress of $2.5 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Healthcare Providers & Services company?
A good Construction In Progress depends on the Healthcare Providers & Services industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on 10x Genomics and its competitors. 10x Genomics's current Construction In Progress is $2.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 10x Genomics stock overvalued right now?
Based on GuruFocus' analysis, 10x Genomics (TXG) is currently considered Significantly Overvalued. The stock's GF Value™ is $19.00, compared to a current price of $36.75 — trading 93.4% above its estimated fair value. The current Construction In Progress is $2.5 Mil. 10x Genomics' overall GF Score™ is 62/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For 10x Genomics (TXG), the current Construction In Progress is $2.5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 10x Genomics (TXG) Overvalued in 2026?

Based on GuruFocus' analysis, 10x Genomics stock appears to be overvalued. The current stock price of $36.75 is trading 93.4% above its estimated GF Value™ of $19.00. GuruFocus considers 10x Genomics to be Significantly Overvalued.

Key valuation signals for TXG:

  • Construction In Progress: $2.5 Mil
  • GF Value™: $19.00 vs. price of $36.75 (93.4% above fair value)
  • GF Score™: 62/100 with 8 warning signs

No single metric tells the full story. See the TXG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

10x Genomics Business Description

Other Exchanges 0A88:UK1KJ:Germany
Address 6230 Stoneridge Mall Road, Pleasanton, CA, USA, 94588
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
62GF Score

Get the complete analysis for TXG

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$36.75
Price
$19.00
GF Value